BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1008 related articles for article (PubMed ID: 28521824)

  • 61. Anti-saccharomyces cerevisiae IgA antibodies are raised in ankylosing spondylitis and undifferentiated spondyloarthropathy.
    Hoffman IE; Demetter P; Peeters M; De Vos M; Mielants H; Veys EM; De Keyser F
    Ann Rheum Dis; 2003 May; 62(5):455-9. PubMed ID: 12695160
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Epidemiology of axial spondyloarthritis: an update.
    Wang R; Ward MM
    Curr Opin Rheumatol; 2018 Mar; 30(2):137-143. PubMed ID: 29227352
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Presence of Fibromyalgia Syndrome and Its Relationship with Clinical Parameters in Patients with Axial Spondyloarthritis.
    Rencber N; Saglam G; Huner B; Kuru O
    Pain Physician; 2019 Nov; 22(6):E579-E585. PubMed ID: 31775411
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Psoriatic Spondylitis: A Disease Manifestation in Debate: Evidences to Know for the Clinical Rheumatologist.
    Zeidler HK
    J Clin Rheumatol; 2022 Jan; 28(1):38-43. PubMed ID: 34941618
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The frequency of uveitis in patients with adult versus childhood spondyloarthritis.
    Turk M; Hayworth J; Nevskaya T; Pope J
    RMD Open; 2020 Aug; 6(2):. PubMed ID: 32868451
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Low grade radiographic sacroiliitis as prognostic factor in patients with undifferentiated spondyloarthritis fulfilling diagnostic criteria for ankylosing spondylitis throughout follow up.
    Huerta-Sil G; Casasola-Vargas JC; Londoño JD; Rivas-Ruíz R; Chávez J; Pacheco-Tena C; Cardiel MH; Vargas-Alarcón G; Burgos-Vargas R
    Ann Rheum Dis; 2006 May; 65(5):642-6. PubMed ID: 16219705
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The incidence of extra-articular manifestations in southern Chinese patients with inflammatory joint diseases.
    Yan S; Cui Y; Zhang X; Zhang G; Dong G; Feng Y; Song Y
    Int J Rheum Dis; 2019 Sep; 22(9):1686-1694. PubMed ID: 31328410
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cardiovascular disease risk profiles in inflammatory joint disease entities.
    Wibetoe G; Ikdahl E; Rollefstad S; Olsen IC; Bergsmark K; Kvien TK; Salberg A; Soldal DM; Bakland G; Lexberg Å; Fevang BT; Gulseth HC; Haugeberg G; Semb AG
    Arthritis Res Ther; 2017 Jul; 19(1):153. PubMed ID: 28673314
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Tuberculosis among patients treated with TNF inhibitors for rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis in Slovenia: a cohort study.
    Rotar Z; Svetina P; Tomsic M; Hočevar A; Prapotnik S
    BMJ Open; 2020 Feb; 10(2):e034356. PubMed ID: 32029494
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Sleep behaviour differs in women and men with psoriatic arthritis and axial spondyloarthritis with impact on quality of life and depressive symptoms.
    Frede N; Rieger E; Lorenzetti R; Venhoff AC; Kanne AM; Finzel S; Jandova I; Glaser C; Thiel J; Voll RE; Venhoff N
    RMD Open; 2023 May; 9(2):. PubMed ID: 37208029
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Comparison of patients with ankylosing spondylitis (AS) and non-radiographic axial spondyloarthritis (nr-axSpA) from a single rheumatology clinic in New Delhi.
    Malaviya AN; Kalyani A; Rawat R; Gogia SB
    Int J Rheum Dis; 2015 Sep; 18(7):736-41. PubMed ID: 26172961
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Disease activity measurements and monitoring in psoriatic arthritis and axial spondyloarthritis.
    Machado PM; Raychaudhuri SP
    Best Pract Res Clin Rheumatol; 2014 Oct; 28(5):711-28. PubMed ID: 25488780
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Risk of venous thromboembolism in ankylosing spondylitis: a general population-based study.
    Aviña-Zubieta JA; Chan J; De Vera M; Sayre EC; Choi H; Esdaile J
    Ann Rheum Dis; 2019 Apr; 78(4):480-485. PubMed ID: 30737222
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Eight-Year Retention Rate of First-Line Tumor Necrosis Factor Inhibitors in Spondyloarthritis: A Multicenter Retrospective Analysis.
    Favalli EG; Selmi C; Becciolini A; Biggioggero M; Ariani A; Santilli D; Fusaro E; Parisi S; Massarotti M; Marchesoni A; Meroni PL
    Arthritis Care Res (Hoboken); 2017 Jun; 69(6):867-874. PubMed ID: 27696735
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Early spondyloarthritis in multiracial society: differences between gender, race, and disease subgroups with regard to first symptom at presentation, main problem that the disease is causing to patients, and employment status.
    Roussou E; Sultana S
    Rheumatol Int; 2012 Jun; 32(6):1597-604. PubMed ID: 21328058
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Epidemiology of spondyloarthritis: a review.
    Bakland G; Nossent HC
    Curr Rheumatol Rep; 2013 Sep; 15(9):351. PubMed ID: 23888360
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Efficacy and safety of adalimumab for the treatment of peripheral arthritis in spondyloarthritis patients without ankylosing spondylitis or psoriatic arthritis.
    Paramarta JE; De Rycke L; Heijda TF; Ambarus CA; Vos K; Dinant HJ; Tak PP; Baeten DL
    Ann Rheum Dis; 2013 Nov; 72(11):1793-9. PubMed ID: 23139265
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Epidemiological and clinical characteristics of psoriatic arthritis in northern Norway.
    Nossent JC; Gran JT
    Scand J Rheumatol; 2009; 38(4):251-5. PubMed ID: 19247847
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Mortality in patients with psoriatic arthritis in Sweden: a nationwide, population-based cohort study.
    Exarchou S; Di Giuseppe D; Klingberg E; Sigurdardottir V; Wedrén S; Lindström U; Turesson C; Jacobsson LTH; Askling J; Wallman JK
    Ann Rheum Dis; 2024 Mar; 83(4):446-456. PubMed ID: 38049985
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Prevalence and distribution of peripheral musculoskeletal manifestations in spondyloarthritis including psoriatic arthritis: results of the worldwide, cross-sectional ASAS-PerSpA study.
    López-Medina C; Molto A; Sieper J; Duruöz T; Kiltz U; Elzorkany B; Hajjaj-Hassouni N; Burgos-Vargas R; Maldonado-Cocco J; Ziade N; Gavali M; Navarro-Compan V; Luo SF; Monti S; Tae-Jong K; Kishimoto M; Pimentel-Santos FM; Gu J; Schiotis R; van Gaalen FA; Geher P; Magrey M; Ibáñez Vodnizza SE; Bautista-Molano W; Maksymowych W; Machado PM; Landewé R; van der Heijde D; Dougados M
    RMD Open; 2021 Jan; 7(1):. PubMed ID: 33462157
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 51.